Los Angeles Capital Management LLC / ALNY
Los Angeles Capital Management LLC’s Alnylam Pharmaceuticals Inc Position
Does Los Angeles Capital Management LLC own Alnylam Pharmaceuticals Inc (ALNY)? Yes — 88.3K shares worth $29M (+0.12% of its 13F portfolio) as of Q1 2026, down from 240.1K shares the prior filed quarter.
Position Value
$29M
Q1 2026
Shares
88.3K
% of Portfolio
+0.12%
Quarters Held
18
currently held
Position History ALNY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 88.3K | $29M | +0.12% |
| Q4 2025 | 240.1K | $108M | +0.37% |
| Q3 2025 | 159.4K | $73M | +0.25% |
| Q2 2025 | 67.4K | $22M | +0.08% |
| Q1 2025 | 80.9K | $22M | +0.10% |
| Q4 2024 | 94.8K | $22M | +0.09% |
| Q3 2024 | 137.0K | $38M | +0.15% |
| Q2 2024 | 1.2K | $288,684 | 0.00% |
| Q1 2024 | 3.0K | $442,223 | 0.00% |
| Q4 2023 | 17.0K | $3M | +0.01% |
| Q2 2023 | 1.5K | $286,240 | 0.00% |
| Q1 2023 | 1.5K | $301,882 | 0.00% |
| Q4 2022 | 2.1K | $491,223 | 0.00% |
| Q3 2022 | 6.1K | $1M | +0.01% |
| Q3 2019 | 4.1K | $328,000 | 0.00% |
| Q2 2019 | 5.1K | $372,000 | 0.00% |
| Q1 2019 | 49.4K | $5M | +0.03% |
| Q4 2018 | 49.8K | $4M | +0.02% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Los Angeles Capital Management LLC’s full portfolio or all institutional holders of ALNY.